191 related articles for article (PubMed ID: 27804123)
1. Enhancing value of clinical pharmacodynamics in oncology drug development: An alliance between quantitative pharmacology and translational science.
Venkatakrishnan K; Ecsedy JA
Clin Pharmacol Ther; 2017 Jan; 101(1):99-113. PubMed ID: 27804123
[TBL] [Abstract][Full Text] [Related]
2. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.
Venkatakrishnan K; Friberg LE; Ouellet D; Mettetal JT; Stein A; Trocóniz IF; Bruno R; Mehrotra N; Gobburu J; Mould DR
Clin Pharmacol Ther; 2015 Jan; 97(1):37-54. PubMed ID: 25670382
[TBL] [Abstract][Full Text] [Related]
3. Clinical Pharmacology: a Discipline at the Nexus Between Translational Science and Precision Medicine: Commentary on "Enhancing Value of Clinical Pharmacodynamics in Oncology Drug Development: An Alliance Between Quantitative Pharmacology and Translational Science".
Vicini P; Roskos LK
Clin Pharmacol Ther; 2017 Jul; 102(1):27-29. PubMed ID: 27984659
[No Abstract] [Full Text] [Related]
4. Translational modeling and simulation approaches for molecularly targeted small molecule anticancer agents from bench to bedside.
Yamazaki S; Spilker ME; Vicini P
Expert Opin Drug Metab Toxicol; 2016; 12(3):253-65. PubMed ID: 26799750
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of tumor size response metrics to predict survival in oncology clinical trials.
Bruno R; Mercier F; Claret L
Clin Pharmacol Ther; 2014 Apr; 95(4):386-93. PubMed ID: 24419563
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic/ pharmacodynamic-driven drug development.
Gallo JM
Mt Sinai J Med; 2010; 77(4):381-8. PubMed ID: 20687184
[TBL] [Abstract][Full Text] [Related]
7. [Side effects of anticancer treatment and the needs for translational research on toxicity: a clinician's perspective].
Shimizu C
Nihon Yakurigaku Zasshi; 2015 Aug; 146(2):72-5. PubMed ID: 26256743
[No Abstract] [Full Text] [Related]
8. Cancer research with a human touch.
May M
Nature; 2018 Apr; 556(7700):259-261. PubMed ID: 29636561
[No Abstract] [Full Text] [Related]
9. Oncology trials gear up for high-throughput sequencing.
Mullard A
Nat Rev Drug Discov; 2012 Apr; 11(5):339-40. PubMed ID: 22543457
[No Abstract] [Full Text] [Related]
10. Tissue-based approaches to study pharmacodynamic endpoints in early phase oncology clinical trials.
Ang JE; Kaye S; Banerji U
Curr Drug Targets; 2012 Nov; 13(12):1525-34. PubMed ID: 22974395
[TBL] [Abstract][Full Text] [Related]
11. Translational paradigms in pharmacology and drug discovery.
Mullane K; Winquist RJ; Williams M
Biochem Pharmacol; 2014 Jan; 87(1):189-210. PubMed ID: 24184503
[TBL] [Abstract][Full Text] [Related]
12. The role of quantitative pharmacology in an academic translational research environment.
Barrett JS
AAPS J; 2008; 10(1):9-14. PubMed ID: 18446501
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic guided trial design in oncology.
van Kesteren Ch; Mathôt RA; Beijnen JH; Schellens JH
Invest New Drugs; 2003 May; 21(2):225-41. PubMed ID: 12889741
[TBL] [Abstract][Full Text] [Related]
14. Towards integrative systems pharmacology models in oncology drug development.
van Hasselt JG; van der Graaf PH
Drug Discov Today Technol; 2015 Aug; 15():1-8. PubMed ID: 26464083
[TBL] [Abstract][Full Text] [Related]
15. American Society of Clinical Oncology Developing First Clinical Trial.
Brower V
J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625
[No Abstract] [Full Text] [Related]
16. Clinical, Pathological, and Ethical Considerations for the Conduct of Clinical Trials in Dogs with Naturally Occurring Cancer: A Comparative Approach to Accelerate Translational Drug Development.
Regan D; Garcia K; Thamm D
ILAR J; 2018 Dec; 59(1):99-110. PubMed ID: 30668709
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Systems Pharmacology: A Case for Disease Models.
Musante CJ; Ramanujan S; Schmidt BJ; Ghobrial OG; Lu J; Heatherington AC
Clin Pharmacol Ther; 2017 Jan; 101(1):24-27. PubMed ID: 27709613
[TBL] [Abstract][Full Text] [Related]
18. Preface. Combining clinical, translational and basic cancer drug research: the 2008 CESAR annual meeting.
Brockmoeller J; Sehrt D; Scheulen ME
Int J Clin Pharmacol Ther; 2009 Jan; 47(1):30-2. PubMed ID: 19203530
[No Abstract] [Full Text] [Related]
19. Array of translational systems pharmacodynamic models of anti-cancer drugs.
Ait-Oudhia S; Mager DE
J Pharmacokinet Pharmacodyn; 2016 Dec; 43(6):549-565. PubMed ID: 27771815
[TBL] [Abstract][Full Text] [Related]
20. [Situation of translational research and development of molecular-targeted agents for multiple myeloma].
Kizaki M
Nihon Rinsho; 2007 Dec; 65(12):2357-61. PubMed ID: 18069283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
